论文信息 - Effect of bevacizumab (BEV) and irinotecan (CPT-11) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in glioblastoma (GBM) patients - 字舞流文

Effect of bevacizumab (BEV) and irinotecan (CPT-11) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in glioblastoma (GBM) patients

D. Barboriak | H. Friedman | D. Reardon | J. Rich | A. Desjardins | J. Vredenburgh | S. Sathornsumetee | J. Herndon | J. Marcello | J. Quinn